Company Overview:
verrica pharmaceuticals inc - VRCA
VRCA Key Data
| Open $6.70 | Day Range 6.70 - 7.07 |
| 52 Week Range 3.28 - 9.82 | Market Cap $114.17M |
| Shares Outstanding 15.99M | Public Float 1.35M |
| Beta 1.46 | Rev. Per Employee N/A |
| P/E Ratio N/A | EPS -$3.44 |
| Yield 0.00% | Dividend N/A |
| EX-DIVIDEND DATE | SHORT INTEREST N/A |
| AVERAGE VOLUME 155.14K |
|
An error occurred while fetching the data.
An error occurred while fetching the data.
Snapshot
| Average Recommendation | BUY | | Average Target Price | 15.333 |
| Number of Ratings | 5 | | Current Quarters Estimate | -0.50 |
| FY Report Date | 03 / 2026 | | Current Year's Estimate | -1.604 |
| Last Quarter’s Earnings | -0.75 | | Median PE on CY Estimate | N/A |
| Year Ago Earnings | -1.086 | | Next Fiscal Year Estimate | -1.11 |
| | | Median PE on Next FY Estimate | N/A |
Earnings Per Share
|
This Quarter
|
Next Quarter
|
This Fiscal
|
Next Fiscal
|
|---|
| # of Estimates | 3 | 3 | 5 | 2 |
| Mean Estimate | -0.50 | -0.40 | -1.60 | -1.11 |
| High Estimates | -0.42 | -0.35 | -0.99 | -0.19 |
| Low Estimate | -0.58 | -0.45 | -2.82 | -2.03 |
| Coefficient of Variance | -16.00 | -12.48 | -46.16 | -117.21 |
Analysts Recommendations
|
Current
|
1 Month Ago
|
3 Months Ago
|
|---|
| BUY |
4
|
4
|
2
|
| OVERWEIGHT |
0
|
0
|
0
|
| HOLD |
1
|
1
|
2
|
| UNDERWEIGHT |
0
|
0
|
0
|
| SELL |
0
|
0
|
0
|
| MEAN |
Buy
|
Buy
|
Overweight
|
An error occurred while fetching the data.